{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:47:36Z","timestamp":1788299256998,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"27","license":[{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1038\/s41388-019-0808-4","type":"journal-article","created":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:03:14Z","timestamp":1557878594000},"page":"5356-5366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["H19 lncRNA identified as a master regulator of genes that drive uterine leiomyomas"],"prefix":"10.1038","volume":"38","author":[{"given":"Tiefeng","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangsheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Al-Hendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramanaiah","family":"Mamillapalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda N.","family":"Kallen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Kodaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh S.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,15]]},"reference":[{"key":"808_CR1","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1055\/s-0030-1251477","volume":"28","author":"SK Laughlin","year":"2010","unstructured":"Laughlin SK, Schroeder JC, Baird DD. New directions in the epidemiology of uterine fibroids. Semin Reprod Med. 2010;28:204\u201317.","journal-title":"Semin Reprod Med"},{"key":"808_CR2","doi-asserted-by":"publisher","first-page":"16043","DOI":"10.1038\/nrdp.2016.43","volume":"2","author":"EA Stewart","year":"2016","unstructured":"Stewart EA, Laughlin-Tommaso SK, Catherino WH, Lalitkumar S, Gupta D, Vollenhoven B. Uterine fibroids. Nat Rev Dis Primers. 2016;2:16043.","journal-title":"Nat Rev Dis Primers"},{"key":"808_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bpobgyn.2015.11.018","volume":"34","author":"AK Styer","year":"2016","unstructured":"Styer AK, Rueda BR. The epidemiology and genetics of uterine leiomyoma. Best Pract Res Clin Obstet Gynaecol. 2016;34:3\u201312.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"808_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1126\/science.1208930","volume":"334","author":"N Makinen","year":"2011","unstructured":"Makinen N, Mehine M, Tolvanen J, Kaasinen E, Li Y, Lehtonen HJ, et al. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science. 2011;334:252\u20135.","journal-title":"Science"},{"key":"808_CR5","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1172\/JCI81534","volume":"125","author":"P Mittal","year":"2015","unstructured":"Mittal P, Shin YH, Yatsenko SA, Castro CA, Surti U, Rajkovic A. Med12 gain-of-function mutation causes leiomyomas and genomic instability. J Clin Invest. 2015;125:3280\u20134.","journal-title":"J Clin Invest"},{"key":"808_CR6","first-page":"592","volume":"158","author":"A Al-Hendy","year":"2017","unstructured":"Al-Hendy A, Laknaur A, Diamond MP, Ismail N, Boyer TG, Halder SK. Silencing Med12 gene reduces proliferation of human leiomyoma cells mediated via Wnt\/beta-catenin signaling pathway. Endocrinology. 2017;158:592\u2013603.","journal-title":"Endocrinology"},{"key":"808_CR7","first-page":"1495","volume":"27","author":"M Bogusiewicz","year":"2012","unstructured":"Bogusiewicz M, Semczuk A, Juszczak M, Langner E, Walczak K, Rzeski W, et al. Expression of matricellular proteins in human uterine leiomyomas and normal myometrium. Histol Histopathol. 2012;27:1495\u2013502.","journal-title":"Histol Histopathol"},{"key":"808_CR8","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2119\/molmed.2014.00053","volume":"21","author":"MA Borahay","year":"2015","unstructured":"Borahay MA, Al-Hendy A, Kilic GS, Boehning D. Signaling pathways in leiomyoma: understanding pathobiology and implications for therapy. Mol Med. 2015;21:242\u201356.","journal-title":"Mol Med"},{"key":"808_CR9","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.fertnstert.2014.10.025","volume":"103","author":"B Aissani","year":"2015","unstructured":"Aissani B, Zhang K, Wiener H. Follow-up to genome-wide linkage and admixture mapping studies implicates components of the extracellular matrix in susceptibility to and size of uterine fibroids. Fertil Steril. 2015;103:528\u201334 e513.","journal-title":"Fertil Steril"},{"key":"808_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bph.13653","volume":"174","author":"SL Wong","year":"2017","unstructured":"Wong SL, Sukkar MB. The SPARC protein: an overview of its role in lung cancer and pulmonary fibrosis and its potential role in chronic airways disease. Br J Pharmacol. 2017;174:3\u201314.","journal-title":"Br J Pharmacol"},{"key":"808_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"XM Meng","year":"2016","unstructured":"Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-beta: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12:325\u201338.","journal-title":"Nat Rev Nephrol"},{"key":"808_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.matbio.2017.12.009","volume":"68-69","author":"JE Murphy-Ullrich","year":"2018","unstructured":"Murphy-Ullrich JE, Suto MJ. Thrombospondin-1 regulation of latent TGF-beta activation: A therapeutic target for fibrotic disease. Matrix Biol. 2018;68-69:28\u201343.","journal-title":"Matrix Biol"},{"key":"808_CR13","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.113.002887","volume":"128","author":"R Liu","year":"2013","unstructured":"Liu R, Jin Y, Tang WH, Qin L, Zhang X, Tellides G, et al. Ten-eleven translocation-2 (TET2) is a master regulator of smooth muscle cell plasticity. Circulation. 2013;128:2047\u201357.","journal-title":"Circulation"},{"key":"808_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.stem.2011.01.008","volume":"8","author":"KP Koh","year":"2011","unstructured":"Koh KP, Yabuuchi A, Rao S, Huang Y, Cunniff K, Nardone J, et al. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell. 2011;8:200\u201313.","journal-title":"Cell Stem Cell"},{"key":"808_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.5","volume":"49","author":"J An","year":"2017","unstructured":"An J, Rao A, Ko M. TET family dioxygenases and DNA demethylation in stem cells and cancers. Exp Mol Med. 2017;49:e323.","journal-title":"Exp Mol Med"},{"key":"808_CR16","doi-asserted-by":"publisher","first-page":"E2437","DOI":"10.1210\/jc.2014-2264","volume":"99","author":"A Navarro","year":"2014","unstructured":"Navarro A, Yin P, Ono M, Monsivais D, Moravek MB, Coon JS. et al. 5-Hydroxymethylcytosine promotes proliferation of human uterine leiomyoma: a biological link to a new epigenetic modification in benign tumors. J Clin Endocrinol Metab. 2014;99:E2437\u20132445.","journal-title":"J Clin Endocrinol Metab"},{"key":"808_CR17","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1073\/pnas.1518752113","volume":"113","author":"M Mehine","year":"2016","unstructured":"Mehine M, Kaasinen E, Heinonen HR, Makinen N, Kampjarvi K, Sarvilinna N, et al. Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers. Proc Natl Acad Sci USA. 2016;113:1315\u201320.","journal-title":"Proc Natl Acad Sci USA"},{"key":"808_CR18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/bies.200900170","volume":"32","author":"A Gabory","year":"2010","unstructured":"Gabory A, Jammes H, Dandolo L. The H19 locus: role of an imprinted non-coding RNA in growth and development. Bioessays. 2010;32:473\u201380.","journal-title":"Bioessays"},{"key":"808_CR19","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/hep.29209","volume":"66","author":"Y Song","year":"2017","unstructured":"Song Y, Liu C, Liu X, Trottier J, Beaudoin M, Zhang L, et al. H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of epithelial cell adhesion molecule. Hepatology. 2017;66:1183\u201396.","journal-title":"Hepatology"},{"issue":"3","key":"808_CR20","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1007\/s10753-018-0744-4","volume":"41","author":"Qingchun Lu","year":"2018","unstructured":"Lu Q, Guo Z, Xie W, Jin W, Zhu D, Chen S, et al. The lncRNA H19 mediates pulmonary fibrosis by regulating the miR-196a\/COL1A1 axis. Inflammation. 2018;41:896\u2013903.","journal-title":"Inflammation"},{"key":"808_CR21","doi-asserted-by":"crossref","first-page":"51473","DOI":"10.18632\/oncotarget.10444","volume":"7","author":"H Xie","year":"2016","unstructured":"Xie H, Xue JD, Chao F, Jin YF, Fu Q. Long non-coding RNA-H19 antagonism protects against renal fibrosis. Oncotarget. 2016;7:51473\u201381.","journal-title":"Oncotarget"},{"key":"808_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.molcel.2013.08.027","volume":"52","author":"AN Kallen","year":"2013","unstructured":"Kallen AN, Zhou XB, Xu J, Qiao C, Ma J, Yan L, et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell. 2013;52:101\u201312.","journal-title":"Mol Cell"},{"key":"808_CR23","first-page":"9","volume":"6","author":"B Aissani","year":"2015","unstructured":"Aissani B, Zhang K, Wiener H. Genetic determinants of uterine fibroid size in the multiethnic NIEHS uterine fibroid study. Int J Mol Epidemiol Genet. 2015;6:9\u201319.","journal-title":"Int J Mol Epidemiol Genet"},{"key":"808_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1055\/s-0030-1251476","volume":"28","author":"N Chegini","year":"2010","unstructured":"Chegini N. Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder. Semin Reprod Med. 2010;28:180\u2013203.","journal-title":"Semin Reprod Med"},{"key":"808_CR25","doi-asserted-by":"publisher","first-page":"996","DOI":"10.15252\/emmm.201505245","volume":"7","author":"S Ghazal","year":"2015","unstructured":"Ghazal S, McKinnon B, Zhou J, Mueller M, Men Y, Yang L, et al. H19 lncRNA alters stromal cell growth via IGF signaling in the endometrium of women with endometriosis. EMBO Mol Med. 2015;7:996\u20131003.","journal-title":"EMBO Mol Med"},{"key":"808_CR26","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/01.LAB.0000017499.51216.3E","volume":"82","author":"SA Carney","year":"2002","unstructured":"Carney SA, Tahara H, Swartz CD, Risinger JI, He H, Moore AB, et al. Immortalization of human uterine leiomyoma and myometrial cell lines after induction of telomerase activity: molecular and phenotypic characteristics. Lab Invest. 2002;82:719\u201328.","journal-title":"Lab Invest"},{"key":"808_CR27","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nsmb.2296","volume":"19","author":"MR Fabian","year":"2012","unstructured":"Fabian MR, Sonenberg N. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol. 2012;19:586\u201393.","journal-title":"Nat Struct Mol Biol"},{"key":"808_CR28","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1101\/gad.1540407","volume":"21","author":"YS Lee","year":"2007","unstructured":"Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 2007;21:1025\u201330.","journal-title":"Genes Dev"},{"key":"808_CR29","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1126\/science.1137999","volume":"315","author":"C Mayr","year":"2007","unstructured":"Mayr C, Hemann MT, Bartel DP. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science (New York, NY). 2007;315:1576\u20139.","journal-title":"Science (New York, NY)"},{"key":"808_CR30","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1038\/onc.2014.236","volume":"34","author":"L Yan","year":"2015","unstructured":"Yan L, Zhou J, Gao Y, Ghazal S, Lu L, Bellone S, et al. Regulation of tumor cell migration and invasion by the H19\/let-7 axis is antagonized by metformin-induced DNA methylation. Oncogene. 2015;34:3076\u201384.","journal-title":"Oncogene"},{"key":"808_CR31","doi-asserted-by":"publisher","first-page":"38398","DOI":"10.18632\/oncotarget.9534","volume":"7","author":"L Zuckerwise","year":"2016","unstructured":"Zuckerwise L, Li J, Lu L, Men Y, Geng T, Buhimschi CS, et al. H19 long noncoding RNA alters trophoblast cell migration and invasion by regulating TbetaR3 in placentae with fetal growth restriction. Oncotarget. 2016;7:38398\u2013407.","journal-title":"Oncotarget"},{"key":"808_CR32","first-page":"174","volume":"105","author":"RA Philibert","year":"1999","unstructured":"Philibert RA, Winfield SL, Damschroder-Williams P, Tengstrom C, Martin BM, Ginns EI. The genomic structure and developmental expression patterns of the human OPA-containing gene (HOPA). Hum Genet. 1999;105:174\u20138.","journal-title":"Hum Genet"},{"key":"808_CR33","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1158\/0008-5472.CAN-07-5282","volume":"68","author":"S Yamashita","year":"2008","unstructured":"Yamashita S, Takahashi S, McDonell N, Watanabe N, Niwa T, Hosoya K, et al. Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers. Cancer Res. 2008;68:2112\u201321.","journal-title":"Cancer Res"},{"key":"808_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.matbio.2014.02.001","volume":"37","author":"O Stenina-Adognravi","year":"2014","unstructured":"Stenina-Adognravi O. Invoking the power of thrombospondins: regulation of thrombospondins expression. Matrix Biol. 2014;37:69\u201382.","journal-title":"Matrix Biol"},{"key":"808_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10221","volume":"6","author":"J Zhou","year":"2015","unstructured":"Zhou J, Yang L, Zhong T, Mueller M, Men Y, Zhang N, et al. H19 lncRNA alters DNA methylation genome-wide by regulating S-adenosylhomocysteine hydrolase. Nat Commun. 2015;6:10221.","journal-title":"Nat Commun"},{"issue":"17","key":"808_CR36","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1038\/onc.2016.391","volume":"36","author":"T Zhong","year":"2016","unstructured":"Zhong T, Men Y, Lu L, Geng T, Zhou J, Mitsuhashi A, et al. Metformin alters DNA methylation genome-wide via the H19\/SAHH axis. Oncogene. 2016;36:2345\u201354.","journal-title":"Oncogene"},{"key":"808_CR37","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.fertnstert.2014.06.050","volume":"102","author":"M Mehine","year":"2014","unstructured":"Mehine M, Makinen N, Heinonen HR, Aaltonen LA, Vahteristo P. Genomics of uterine leiomyomas: insights from high-throughput sequencing. Fertil Steril. 2014;102:621\u20139.","journal-title":"Fertil Steril"},{"key":"808_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/humupd\/dmx032","volume":"24","author":"MS Islam","year":"2018","unstructured":"Islam MS, Ciavattini A, Petraglia F, Castellucci M, Ciarmela P. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics. Hum Reprod Update. 2018;24:59\u201385.","journal-title":"Hum Reprod Update"},{"key":"808_CR39","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1210\/en.2009-1225","volume":"151","author":"H Ishikawa","year":"2010","unstructured":"Ishikawa H, Ishi K, Serna VA, Kakazu R, Bulun SE, Kurita T. Progesterone is essential for maintenance and growth of uterine leiomyoma. Endocrinology. 2010;151:2433\u201342.","journal-title":"Endocrinology"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-019-0808-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-019-0808-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-019-0808-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:16:08Z","timestamp":1684617368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-019-0808-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,15]]},"references-count":39,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["808"],"URL":"https:\/\/doi.org\/10.1038\/s41388-019-0808-4","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,15]]},"assertion":[{"value":"29 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}